Cardiovascular disease in people living with HIV in Malaysia: A competing risks cohort analysis
HIV Medicine · 2026
DOI: 10.1111/hiv.70145 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIV Medicine, 2026. Verfasst von Hoon Shien Teh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Clinical Epidemiology, Institute for Clinical Research, National Institutes of Health, Ministry of Health, Setia Alam, Malaysia. Hauptthemen laut MEDLINE: HIV Infections, Cardiovascular Diseases. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Ministry of Health Malaysia research grant.
Abstract (Originalsprache)
Purpose
Cardiovascular disease (CVD) is an emerging health concern among people living with HIV (PLHIV), particularly in Asian settings where evidence remains limited. We aimed to estimate the cumulative risk of CVD among PLHIV in Malaysia, in the presence of competing risk from non‐CVD deaths, and to identify associated risk factors.
Methods
We conducted a retrospective cohort study using data from the Malaysian Antiretroviral Therapy Cohort (MATCH), including adults diagnosed with HIV between 2007 and 2023. Individuals with prior CVD were excluded. The primary outcome was a composite of CVD events, with non‐CVD death treated as a competing risk. We estimated cumulative incidence functions (CIFs) and incidence rates (IRs) per 1000 person‐years (PYs), and assessed associations using Fine and Grey subdistribution hazard models, with cause‐specific Cox models as secondary analysis.
Results
Among 7098 PLHIV, 287 (4.0%) developed CVD over 61 936 PY (IR: 4.63 per 1000 PY; 95% CI: 4.11–5.20). The cumulative CVD risk was 1.9% at 5 years, 3.8% at 10 years, and 7.1% at 15 years post‐diagnosis. Older age (subdistribution hazard ratio (sHR): 1.07 per year), Indian (sHR: 2.27), and Malay ethnicity (sHR: 1.81) were associated with a higher risk. Abacavir use was significantly associated with CVD (sHR: 2.48). PI use showed a borderline association in the main model (sHR: 1.47) but was significant in the secondary analysis (aHR: 1.86). Other antiretroviral classes were not significant.
Conclusion
CVD risk among PLHIV is non‐negligible. Integrating CVD prevention into HIV care is critical, particularly for older adults and those on specific ART regimens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Clinical Epidemiology, Institute for Clinical Research, National Institutes of Health, Ministry of Health, Setia Alam, Malaysia.
- Department of Internal Medicine, Sungai Buloh Hospital, Ministry of Health, Sungai Buloh, Malaysia.
- Centre for Clinical Care and Outcomes Research, Institute for Clinical Research, National Institutes of Health, Ministry of Health, Setia Alam, Malaysia.
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
ORCID-Profile: Hoon Shien Teh
Förderung
- Ministry of Health Malaysia research grant
Zitieren
APA
Teh, H. S., Tay, K. H., Lim, Y. M. F., Yang, S. L., Lee, J. L., Anand, S., Sim, B. L. H., & Hwong, W. Y. (2026). Cardiovascular disease in people living with HIV in Malaysia: A competing risks cohort analysis. HIV Medicine. https://doi.org/10.1111/hiv.70145
Vancouver
Teh HS, Tay KH, Lim YMF, Yang SL, Lee JL, Anand S, et al. Cardiovascular disease in people living with HIV in Malaysia: A competing risks cohort analysis. HIV Medicine. 2026. doi:10.1111/hiv.70145
BibTeX
@article{Teh2026,
author = {Teh, Hoon Shien and Tay, Kim Heng and Lim, Yvonne Mei Fong and Yang, Su Lan and Lee, Jie Ling and Anand, Shailesh and Sim, Benedict Lim Heng and Hwong, Wen Yea},
title = {Cardiovascular disease in people living with HIV in Malaysia: A competing risks cohort analysis},
journal = {HIV Medicine},
year = {2026},
doi = {10.1111/hiv.70145}
}
EUVIMED